LINAVONKIBART
UNII 8SSL98OST3

Substance Identification & Data

This profile provides standardized clinical and technical data for Linavonkibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8SSL98OST3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2640981-30-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8SSL98OST3

CAS Registry Number

2640981-30-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LINAVONKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C173598

National Cancer Institute reference terminology for clinical and research data.

INN ID

12283

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-207

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Linavonkibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LINAVONKIBART

Common Names & Synonyms

IMMUNOGLOBULIN G4 (228-PROLINE,DE-447-LYSINE), ANTI-(HUMAN TRANSFORMING GROWTH FACTOR .BETA.1 LARGE LATENT COMPLEX) (HUMAN MONOCLONAL SRK-181 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL SRK-181 .KAPPA.-CHAIN, DIMER

IMUNOGLOBULIN G4-KAPPA, ANTI-(TGFB1 (TRANSFORMING GROWTH FACTOR BETA1, TGF BETA)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-446) (VH (HOMO SAPIENS IGHV3-48*01 (92.9%) -(IGHD) -IGHJ5*02 (100%), CDR-IMGT (8.8.13) (26-33.51-58.97-109)) (1-120)-HOMO SAPIENS IGHG4*01,G4V5 H P10, NG4M(A) CH2 L92 (CH1 (121-218), HINGE 1-12 S10>P (228) (219-230), CH2 L92 (309)(231-340), CH3 (341-445), CHS K2>DEL (446))(121-446)), (134-215')-DISULFIDEWITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-215') (V-KAPPA (HOMO SAPIENS IGKV1-33*01 (96.8%) -IGKJ4*01 (100%), CDR-IMGT (6.3.10) (27-32.50-52.89-98)) (1'-108')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (154), V101 (192)(109'-215')); DIMER(226-226'':229-229'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS,GLYCOFORM ALFA

LINAVONKIBART [INN]

LINAVONKIBART [USAN]

LINAVONKIBART [WHO-DD]

SRT.BETA.1-AB3

SRT.BETA.1-AB3 (A FULLY HUMAN, ISOFORM-SPECIFIC ANTI-LATENT TGF.BETA.1 ANTIBOD)